Achondroplasia, a rare disease that is caused by an activating mutation in the fibroblast growth factor receptor 3 (FGFR3) gene, affects endochondral ossification and disrupts long bone growth, leading to skeletal disproportion with short stature (125 to 134 cm average adult height) [1,2,3,4,5]. Here, FGFR3 is linked to achondroplasia.